Results per Page:

Mapping tumor cell heterogeneity in castrate-resistant prostate cancer
From the Haffner Lab, Human Biology and Clinical Research Divisions

Vaccine targets that accommodate evolving SARS-CoV-2 variants
From the Overbaugh Lab, Human Biology and Public Health Sciences Divisions

More to brain tumors than meets the eye
Fred Hutch researchers find new way to classify tumors based on their underlying biology rather than how they look

Pancreatic ductal adenocarcinoma subtypes: what your type means?
From the Kugel Lab, Human Biology Division

Degrade, degrade oncoproteins! PROTACs, a new strategy to kill cancer cells
From the Nabet Lab, Human Biology Division

Accepting glowing cells as one’s own allows immune competent metastatic studies
From the Ghajar Lab, Public Health Sciences and Human Biology Divisions

New strategy to weather the (cytokine) storm
From the Gujral Lab, Human Biology Division

A Passport to Cross-species Transmission
From the Emerman Lab, Human Biology Division

A new path forward: A potential route to effective HIV vaccines
From the Overbaugh Lab, Human Biology Division

Untranslated, maybe, unappreciated, no more.
From the Hsieh Lab, Human Biology Division

Sleeping Beauty awakens erythroleukemia drivers
From the Clurman lab, Human Biology and Clinical Research Division

Prostate cancer patient selection for cell-free DNA testing
From the Pritchard and Nelson labs and Prostate Cancer Program, University of Washington and Human Biology Division

Protection of HIV-1 infected adolescents against HPV-related cancers in Africa
From the Galloway lab, Human Biology Division

A tip from skin cells to keep tumor initiation under control
From the Beronja Lab, Human Biology Division

H. pylori and gastric cancer: new considerations for East Asian populations
From the Salama Laboratory, Human Biology Division

The aged microenvironment is a favorable niche for prostate cancer
From the Nelson Laboratory, Human Biology Division

Personalized medicine for head and neck cancer
from the Mendez lab, Clinical Research Division, and Kemp lab, Human Biology Division

Machine learning provides new insights into tumor suppression
Algorithm illuminated surprising metabolic effects of important cancer gene

Jump-starting innovative projects exploring pathogen-associated cancers
Pathogen-Associated Malignancies Integrated Research Center awards first round of pilot funding supporting researchers studying H. pylori, EBV and the microbiome

Preventing chemo-induced hearing loss
A new drug in development could avert permanent hearing loss associated with some chemotherapies, antibiotics